公众号 / 文章心脑血管急症创伤与烧伤重症综合管理与镇静镇痛

轻中度创伤性脑损伤后挽救大脑:维持脑灌注的生理学新见解报告

Saving the brain after mild-to-moderate traumatic injury: A report on new insights of the physiology underlying adequate maintenance of cerebral perfusion.
PubMed 文献 · J Trauma Acute Care Surg · 2021-01-01
一句话结论本报告提出,通过阻抗阈值装置产生吸气阻力实施胸腔内压调节治疗,可能改善轻中度创伤性脑损伤患者的脑灌注,在损伤现场提供早期神经保护并作为确定性治疗的桥接。

本文为报告类文章,聚焦轻中度创伤性脑损伤后脑灌注不足的急性无创治疗。作者提出利用吸气时胸腔内负压自然转移的胸腔内压调节(IPR)治疗,通过阻抗阈值装置让患者对抗小吸气阻力呼吸。该治疗基于两个原则:更大的胸腔内负压增强静脉回流、心输出量和动脉血压;降低颅内压减少脑血流阻力,两者共同产生更大压力梯度以改善脑灌注压。作者认为该治疗有可能对抗低血压和缺氧,在轻中度TBI患者中提供损伤现场早期神经保护并作为确定性治疗的桥接。

要点

  • 创伤性脑损伤在 civilian trauma 和 battlefield settings 中与发病率和死亡率增加相关,战斗伤员中高达80%至90%的病例诊断为轻中度。
  • IPR治疗通过阻抗阈值装置让患者对抗小吸气阻力呼吸实施,利用吸气时胸腔内负压的自然转移。
  • IPR治疗改善脑血流的两个原则:更大的胸腔内负压增强静脉回流、心输出量和动脉血压;降低颅内压减少脑血流阻力。
  • 作者认为IPR治疗有可能对抗低血压和缺氧,后者可能是继发性脑损伤的重要 contributing factors,尤其在包括严重出血的多发伤情况下。
  • 作者认为在轻中度TBI患者中实施IPR治疗,有可能在损伤现场提供早期神经保护并作为确定性治疗的桥接,尤其在预计未来多域作战中 evacuation 延迟的情况下。

适用人群与场景

  • 轻中度创伤性脑损伤患者,包括 civilian trauma 和 battlefield settings 中的战斗伤员(战斗伤员中高达80%至90%的病例诊断为轻中度)。
  • 尤其适用于包括严重出血的多发伤情况下,以及预计 evacuation 延迟的场景如未来多域作战。

处置流程与药物剂量

  • IPR治疗通过让患者对抗由阻抗阈值装置产生的小吸气阻力呼吸来实施。
  • IPR治疗利用两个原则:更大的胸腔内负压增强静脉回流、心输出量和动脉血压;降低颅内压减少脑血流阻力,两者共同产生更大压力梯度改善脑灌注压。

研究设计与关键结果

  • 本文为报告,提出利用吸气时胸腔内负压自然转移的IPR治疗轻中度TBI相关脑灌注不足的框架。
  • 作者认为IPR治疗有可能对抗低血压和缺氧,后者可能是继发性脑损伤的重要 contributing factors,尤其在包括严重出血的多发伤情况下。
  • 作者认为在轻中度TBI患者中实施IPR治疗,有可能在损伤现场提供早期神经保护并作为确定性治疗的桥接,尤其在预计未来多域作战中 evacuation 延迟的情况下。

证据类型、等级与局限

  • 证据类型:报告(LEVEL OF EVIDENCE: Report)。
  • 局限:原文未报告局限性

对床旁实践的改变

  • 作者认为,在轻中度TBI患者中实施IPR治疗,有可能在损伤现场提供早期神经保护并作为确定性治疗的桥接,尤其在预计 evacuation 延迟的场景如未来多域作战。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

ABSTRACT: Traumatic brain injury (TBI) is associated with increased morbidity and mortality in civilian trauma and battlefield settings. It has been classified across a continuum of dysfunctions, with as much as 80% to 90% of cases diagnosed as mild to moderate in combat casualties. In this report, a framework is presented that focuses on the potential benefits for acute noninvasive treatment of reduced cerebral perfusion associated with mild TBI by harnessing the natural transfer of negative intrathoracic pressure during inspiration. This process is known as intrathoracic pressure regulation (IPR) therapy, which can be applied by having a patient breath against a small inspiratory resistance created by an impedance threshold device. Intrathoracic pressure regulation therapy leverages two fundamental principles for improving blood flow to the brain: (1) greater negative intrathoracic pressure enhances venous return, cardiac output, and arterial blood pressure; and (2) lowering of intracranial pressure provides less resistance to cerebral blood flow. These two effects work together to produce a greater pressure gradient that results in an improvement in cerebral perfusion pressure. In this way, IPR therapy has the potential to counter hypotension and hypoxia, potentially significant contributing factors to secondary brain injury, particularly in conditions of multiple injuries that include severe hemorrhage. By implementing IPR therapy in patients with mild-to-moderate TBI, a potential exists to provide early neuroprotection at the point of injury and a bridge to more definitive care, particularly in settings of prolonged delays in evacuation such as those anticipated in future multidomain operations.

LEVEL OF EVIDENCE: Report.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Convertino VA, Cardin S, Cap AP, et al. Saving the brain after mild-to-moderate traumatic injury: A report on new insights of the physiology underlying adequate maintenance of cerebral perfusion. J Trauma Acute Care Surg. 2021. PMID: 34039933. doi:10.1097/TA.0000000000003286

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。